Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes
Clinical trial NCT00974090 · COMPLETED
Trial details
- NCT number
- NCT00974090
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-03-01
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.